Pharma's AI Revolution: Hidden Gems for Smart Investors

Pharmaceutical stocks have been overlooked for years. But now, AI is changing the game. It can speed up drug development. This could cut the time from 15 years to just 6. That's big news for the industry. Two companies stand out. Becton Dickinson (BDX) and the BlackRock Health Sciences Fund (BME). They are not the usual suspects. But they could be big winners. BDX makes hospital supplies. Syringes, needles, catheters. They also make lab equipment. AI will boost demand for these products. The company is merging with Waters Corporation. This deal will bring growth and cash. BDX pays a 2. 8% dividend. It's a good buy now.BME is a closed-end fund. It holds stocks of medical-device makers. Abbott Laboratories, Thermo Fisher Scientific. It also has drugmakers like Lilly and Amgen. BME pays a 7. 8% dividend. That's a lot! It trades at a discount. This means it's cheap right now. AI is a game-changer for pharma. It cuts costs and speeds up drug development. This could lead to big profits. Investors should look at BDX and BME. They are well-positioned to benefit from this trend.